International Journal of Drug Delivery Technology
Volume 14, Issue 2

Formulation and Characterization of Isoconazole Loaded Invasomal Gel for Effective Antifungal Activity

Dhananjay Chavan*, Manish Kumar

Department of Pharmacy, Madhav University, Pindwara, Rajasthan, India

Received: 05th January, 2024; Revised: 08th March, 2024; Accepted: 19th May, 2024; Available Online: 25th June, 2024 

ABSTRACT

The characterization of isoconazole invasomal gel formulations (IG1–IG5) aimed to evaluate their physical attributes, drug content, and drug release kinetics for topical application. All formulations exhibited transparency and smooth texture, indicating uniform drug dispersion. While IG1 had an easily pourable consistency, IG4 displayed very good consistency, suggesting viscosity differences. Despite these variations, all formulations showed good homogeneity and high drug content, with IG4 leading in drug content percentage. Spreadability and viscosity varied among formulations, influencing ease of application and adherence to the skin. Cumulative drug release profiles revealed sustained release over 12 hours, with notable differences in release rates and extents among formulations. IG4 exhibited the most sustained release, aligning with pharmacokinetic requirements for antifungal therapy. Its release profile followed a diffusion-controlled mechanism, with a high cumulative drug release percentage of 98.95 ± 0.32% over 12 hours. Antifungal activity against Candida albicans was comparable to Isoconazole, suggesting IG4’s effectiveness in treating fungal infections. Stability studies confirmed the formulation’s stability under tested conditions, supporting its potential for further development and clinical use.

Keywords: Isoconazole, Invasomal gel formulations, Drug release kinetics, Sustained release, Antifungal activity, Stability studies.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.47

How to cite this article: Chavan D, Kumar M. Formulation and Characterization of Isoconazole Loaded Invasomal Gel for Effective Antifungal Activity. International Journal of Drug Delivery Technology. 2024;14(2):919-924.

REFERENCES

  1. Shivatare R, Jangra S, Gaikwad A, Kewatkar S, Bhutale N, Suryavanshi DS, Tare Development and validation of ICPMS methods for simultaneous determination of elemental impurities in topical cream containing ximenynic acid. Future Journal of Pharmaceutical Sciences. 2023 Jun 2;9(1):47.
  2. Akhtar N, Verma A, Pathak K. Topical delivery of drugs for the effective treatment of fungal infections of skin. Current pharmaceutical design. 2015 Jun 1;21(20):2892-913.
  3. Jadhao U, Tare H, Jain SK. Skin Penetrating Lipid Vesicles: Ethosomes in Drug Delivery and Cosmeceuticals. International Journal of Drug Delivery Technology. 2024;14(1):496-505.
  4. Lortholary O, Dupont B. Antifungal prophylaxis during neutropenia and immunodeficiency. Clinical microbiology reviews. 1997 Jul;10(3):477-504.
  5. Sengupta P, Chatterjee B, Tekade RK. Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: A comprehensive review. International journal of pharmaceutics. 2018 May 30;543(1-2):328-44.
  6. Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. Journal of Controlled Release. 2008 Apr 7;127(1):59-69.
  7. Kumari S, Alsaidan OA, Mohanty D, Zafar A, Das S, Gupta JK, Khalid M. Development of Soft Luliconazole Invasomes Gel for Effective Transdermal Delivery: Optimization to In-Vivo Antifungal Activity. Gels. 2023 Aug 3;9(8):626.
  8. Kumar B, Manchanda S. Development of eucalyptol enriched nano vesicles for better transdermal delivery of curcumin: Preparation, characterisation and ex vivo skin analysis. Nanomedicine Journal. 2022 Jul 1;9(3): 223–230.
  9. Chandra A, Aggarwal G, Manchanda S, Narula Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharmaceutical nanotechnology. 2019 Dec 1;7(5):362-74.
  10. Bachhav YG, Patravale VB. Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies. Aaps Pharmscitech. 2009 Jun;10:476-81.
  11. Sareen R, Kumar S, D Gupta G. Meloxicam carbopol-based gels: characterization and evaluation. Current Drug Delivery. 2011 Jul 1;8(4):407-15.
  12. Mane V, Killedar S, More H, Tare Preclinical study on camellia sinensis extract-loaded nanophytosomes for enhancement of memory-boosting activity: optimization by central composite design. Future Journal of Pharmaceutical Sciences. 2024 May 1;10(1):66.
  13. Kumar B, Sahoo PK, Manchanda Formulation, characterization and ex vivo study of curcumin nano-invasomal gel for enhanced transdermal delivery. OpenNano. 2022 Jul 1;7:100058.
  14. Aslam M, Aqil M, Ahad A, Najmi AK, Sultana Y, Ali A. Application of Box–Behnken design for preparation of glibenclamide loaded lipid based nanoparticles: Optimization, in vitro skin permeation, drug release and in vivo pharmacokinetic study. Journal of Molecular Liquids. 2016 Jul 1;219:897-908.
  15. Higuchi TJ. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of pharmaceutical sciences. 1963 Dec;52(12):1145-9.
  16. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic International journal of pharmaceutics. 1983 May 1;15(1):25-35.
  17. Vishwakarma R, Tare H, Jain SK. Regulating Drug Release with Microspheres: Formulation, Mechanisms, and Challenges. International Journal of Dr ug Delivery 2024;14(1):487-495.